How Translation Teamwork Generates Cost Savings For Global Trials

Each phase of a clinical trial involves an intricate dance among collaborating parties. A successful trial hinges upon the ability of multiple vendors to support the trial sponsor in a series of interlocking steps that can feel as complex and multi-faceted as the disease the sponsor is striving to treat.

At any time, various vendors—from language service providers (LSPs) to CROs to eCOA providers—must work together to drive efficiency and ensure the quality and accuracy of trial data. Now more than ever, as companies seek to do more with less, collaboration is key.

Historically, trial partners have viewed the implementation of translations of electronic clinical outcome assessments (eCOAs) as a lengthy and sometimes overly complicated part of the process, largely because it requires so much time and manpower to complete correctly. Effective eCOA translation, however, need not be painful or budget-breaking. When trial vendors work collaboratively to innovate and streamline processes, they create efficiencies and generate cost-savings that simplify their work and benefit the trial sponsor—and, ultimately, the patient. RWS and Clinical Ink worked together in just such a way. Their collaboration led to a more streamlined process to review translated eCOA screens, which has simplified work for both teams and yielded significant benefits for the sponsor client.

Here’s how the two teams worked together to create something better.